Gene · 64761
Papers1,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elucidating the role of LGALS3BP in coronary atherosclerosis: integrating bioinformatics and machine learning for advanced insights. | J Cardiothorac Surg | 2025 | 40814096 | PubTator, text mining | PubMed |
| Identification of a prognostic signature consisting of three macrophage-related genes for glioblastoma based on bulk and single-cell transcriptomes analyses. | Ann Med | 2025 | 40810678 | PubTator, text mining | PubMed |
| Rewiring DNA repair with PARP-based chemical inducers of proximity. | bioRxiv | 2025 | 40766430 | PubTator, text mining | PubMed |
| SLFN11: a pan-cancer biomarker for DNA-targeted drugs sensitivity and therapeutic strategy guidance. | Front Oncol | 2025 | 40766331 | PubTator, text mining | PubMed |
| Mono-ADP-ribosylating PARP enzymes in cellular signaling and disease. | J Cell Sci | 2025 | 40741921 | PubTator, text mining | PubMed |
| PARP9-PARP13-PARP14 axis tunes colorectal cancer response to radiotherapy. | J Exp Clin Cancer Res | 2025 | 40646573 | PubTator, text mining | PubMed |
| Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors. | MedComm (2020) | 2025 | 40636285 | PubTator, text mining | PubMed |
| PARP12-mediated mono-ADP-ribosylation as a checkpoint for necroptosis and apoptosis. | Proc Natl Acad Sci U S A | 2025 | 40489618 | PubTator, text mining | PubMed |
| Insulin post-transcriptional regulation via PARP12-mediated ADP- ribosylation. | Res Sq | 2025 | 40470236 | PubTator, text mining | PubMed |
| Impact of the Zinc Antiviral Protein on the Genomic Composition of RNA Viruses Infecting Vertebrates. | Mol Biol Evol | 2025 | 40465846 | PubTator, text mining | PubMed |
| Widespread false negatives in DNA-encoded library data: how linker effects impair machine learning-based lead prediction. | Chem Sci | 2025 | 40395382 | PubTator, text mining | PubMed |
| Adenosine diphosphate-ribosylation greatly affects proteins function: a focus on neurodegenerative diseases. | Front Aging Neurosci | 2025 | 40370754 | PubTator, text mining | PubMed |
| Joining of DNA breaks- interplay between DNA ligases and poly (ADP-ribose) polymerases. | DNA Repair (Amst) | 2025 | 40347914 | PubTator, text mining | PubMed |
| CRISPR Screens Identify POLB as a Synthetic Lethal Enhancer of PARP Inhibition Exclusively in BRCA-Mutated Tumors. | Mol Cancer Ther | 2025 | 40326293 | PubTator, text mining | PubMed |
| Unveiling Promising PARP12 Inhibitors through Virtual Screening for Cancer Therapy. | Curr Pharm Des | 2025 | 40265429 | PubTator, text mining | PubMed |
| Engaging an engineered PARP-2 catalytic domain mutant to solve the complex structures harboring approved drugs for structure analyses. | Bioorg Chem | 2025 | 40228437 | PubTator, text mining | PubMed |
| Investigation of mitochondrial DNA methylation-related prognostic biomarkers in hepatocellular carcinoma using The Cancer Genome Atlas (TCGA) database. | Transl Cancer Res | 2025 | 40224972 | PubTator, text mining | PubMed |
| Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer. | Lab Invest | 2025 | 40210166 | PubTator, text mining | PubMed |
| H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition. | Neuro Oncol | 2025 | 40207661 | PubTator, text mining | PubMed |
| Employing a Highly Potent Fluorescence Probe to Discover a Poly (Adenosine Diphosphate-ribose) Polymerases-1/2 Binder and the Complex Structures Analysis. | ChemMedChem | 2025 | 40204633 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64761/papers?page=4